The need for international multicentre collaborative studies to better characterise the clinical profile of anti-Th/To-positive patients: reply to the comment by Sakaida et al
Clin Exp Rheumatol. 2024 Feb 19.
doi: 10.55563/clinexprheumatol/3985jv.
Online ahead of print.
1 Scleroderma Unit, Rheumatology and Clinical Immunology Unit, ASST Spedali Civili of Brescia, and Department of Clinical and Experimental Sciences, University of Brescia, Italy. l.moschetti001@unibs.it.
2 Scleroderma Unit, Rheumatology and Clinical Immunology Unit, ASST Spedali Civili of Brescia, Italy.
3 Scleroderma Unit, Rheumatology and Clinical Immunology Unit, ASST Spedali Civili of Brescia, and Departement of Clinical and Experimental Sciences, University of Brescia, Italy.